COMPOSITION:Each 1 ml contains:
Buparvaquone 50 mg
Buparvaquone is a second-generation hydroxynaphthoquinone related to parvaquone, with novel features that make it a promising compound for the therapy and prophylaxis of all forms of theileriosis. It has been tested extensively against Theileria annulata, T. parva and T. sergenti, both in laboratory studies and in field trials, and it has undergone a rigorous programme of toxicology and safety studies. Formulated as a solution for intramuscular injection (Butalex, Coopers Animal Health), it offers a safe and convenient alternative to existing antitheilerial products.
AVIQUONE is an anti-theilerial treatment used in treating Bovine theileriosis (which is known also as East Coast fever, Corridor disease and Tropical theileriosis) in Ruminants caused by Theileria annulata, T. mutans, T. parva, and T. orientalis (sergenti). Its activity covers both the schizont and piroplasm phases of Theileria could be also used in the incubation period of the disease, or in the clinical phase of the disease.
Dosage and administration:
ONLY To be Injected by deep intramuscular injection
Cattle: 1 ml of AVIQUONE per 20 kg body weight (Equivalent to 2.5 mg buparvaquone per kg body weight).
In severe cases another injection with same dose is needed after 2-3 days of the first injection.
- Divide the dose so you do not administer more than 10 ml into each injection site.
Local, oedematous swelling may be seen at the injection site.
Buparvquone has some immuno-compromising effects; so avoid vaccinating animals during treatment with Buparvaquone.
AVIQUONE should NEVER be given by intravenous or subcutaneous injection.
Meat: 42 days.
Milk: should be discarded in the 48 hours following the last treatment.
Store in a dark place at a temperature below 30C.
20 & 40 ml Amber glass bottles
FOR VETERINARY USE ONLY